Comparison of biologics and small-molecule drugs in axial spondyloarthritis: a systematic review and network meta-analysis

Background: Biologics and small-molecule drugs have become increasingly accepted worldwide in the treatment of axial spondyloarthritis (axSpA), including ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA). However, a quantitative multiple comparison of their efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Erye, Wu, Jian, Zeng, Keqin, Wang, Mingjun, Yin, Yufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628508/
https://www.ncbi.nlm.nih.gov/pubmed/37942485
http://dx.doi.org/10.3389/fphar.2023.1226528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628508/
https://www.ncbi.nlm.nih.gov/pubmed/37942485
http://dx.doi.org/10.3389/fphar.2023.1226528

Ejemplares similares